Benefits of β-glucans in patients with breast cancer: systematic literature review
-
Published:2024-04-23
Issue:00
Volume:3
Page:e058
-
ISSN:2764-9512
-
Container-title:Journal of Medical Residency Review
-
language:
-
Short-container-title:jmrr
Author:
Ferraz de Oliveira Carolina Trabasso,Seto de Oliveira Giovanna,Fernandes Junior Hezio Jadir Fernandes Junior,Tallo Fernando Sabia,Caricati-Neto Afonso,Tantray Junaid,Viana Bianca Lorayne de Almeida,Rodrigues Francisco Sandro Menezes
Abstract
Breast cancer is the most prevalent cancer, totaling 50 thousand new cases per year, as well as being responsible for a high annual mortality rate. Some preventive measures are simple and easy to carry out, such as practicing physical activities, eating a healthy diet, not smoking, avoiding drinking alcohol, carrying out self-examinations and mammograms frequently. Several recent studies have demonstrated that the consumption of nutraceuticals rich in beta-glucans (β-glucans) can have a positive impact on both the prevention and treatment of breast cancer. β-glucans are natural polysaccharides found in the cell walls of fungi and yeast that promote the stimulation of cells that make up the immune system and modulation of tumor cells.
Publisher
Editora Alumniin
Reference23 articles.
1. Jamal-Hanjani, M.; Wilson, G. A.; McGranahan, N.; Birkbak, N. J.; Watkins, T.; Veeriah, S.; Shafi, S.; Johnson, D. H.; Mitter, T.; Rosenthal, R.; Salm, M.; Horswell, S.; Escudero, M.; Matthews, N.; Rowan, A.; Chambers, T.; Moore, D. A.; Turajlic, S.; Xu, H.; Lee, S. M., … TRACERx Consortium. Tracking the evolution of non-small-cell lung cancer. New England Journal of Medicine 2017, 376, 2109-2121. 2. Sagar, B.; Lin, Y.S.; Castel, L.D. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective. Journal of Medical Economics 2017, 20, 1018–1023. 3. Morigi, C. Highlights from the 15th St Gallen International Breast Cancer Conference, Vienna: tailored treatments for patients with early breast cancer. Ecancermedicalscience 2017, 11, 732. 4. Carling, D. AMPK signalling in health and disease. Current Opinion in Cell Biology 2017, 45, 31–37. 5. Errante, P.R.; Neto, A.C.; Bergantin, L. B. Insights for the inhibition of cancer progression: Revisiting Ca2+ and cAMP signalling pathways. Advances in Cancer Prevention 2017, 2, e103.
|
|